| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Geron Corporation, Menlo Park, California 94025, USA, and
Department of Pathology, University of Washington, Seattle, Washington 98195, USA
1Correspondence: Geron Corporation, 230 Constitution Drive, Menlo Park, CA 94025, USA. E-mail: dchoi{at}geron.com
Reduced replicative capacity is a consistent characteristic of cells derived from patients with Werner syndrome. This premature senescence is phenotypically similar to replicative senescence observed in normal cell strains and includes altered cell morphology and gene expression patterns. Telomeres shorten with in vitro passaging of both WRN and normal cell strains; however, the rate of shortening has been reported to be faster in WRN cell strains, and the length of telomeres in senescent WRN cells appears to be longer than that observed in normal strains, leading to the suggestion that senescence in WRN cell strains may not be exclusively associated with telomere effects. We report here that the telomere restriction fragment length in senescent WRN fibroblasts cultures is within the size range observed for normal fibroblasts strains and that the expression of a telomerase transgene in WRN cell strains results in lengthened telomeres and replicative immortalization, thus indicating that telomere effects are the predominant trigger of premature senescence in WRN cells. Microarray analyses showed that mRNA expression patterns induced in senescent WRN cells appeared similar to those in normal strains and that hTERT expression could prevent the induction of most of these genes. However, substantial differences in expression were seen in comparisons of early-passage and telomerase-immortalized derivative lines, indicating that telomerase expression does not prevent the phenotypic drift, or destabilized genotype, resulting from the WRN defect.—Choi, D., Whittier, P. S., Oshima, J., Funk, W. D. Telomerase expression prevents replicative senescence but does not fully reset mRNA expression patterns in Werner syndrome cell strains.
Key Words:
This article has been cited by other articles:
|
|
 |
|
  A. S. Multani and S. Chang WRN at telomeres: implications for aging and cancer J. Cell Sci., March 1, 2007; 120(5): 713 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sharma, D. J. Stumpo, A. S. Balajee, C. B. Bock, P. M. Lansdorp, R. M. Brosh Jr., and P. J. Blackshear RECQL, a Member of the RecQ Family of DNA Helicases, Suppresses Chromosomal Instability Mol. Cell. Biol., March 1, 2007; 27(5): 1784 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Eller, X. Liao, S. Liu, K. Hanna, H. Backvall, P. L. Opresko, V. A. Bohr, and B. A. Gilchrest A role for WRN in telomere-based DNA damage responses PNAS, October 10, 2006; 103(41): 15073 - 15078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Bailey and J. P. Murnane Telomeres, chromosome instability and cancer. Nucleic Acids Res., January 1, 2006; 34(8): 2408 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Szekely, F. Bleichert, A. Numann, S. Van Komen, E. Manasanch, A. Ben Nasr, A. Canaan, and S. M. Weissman Werner Protein Protects Nonproliferating Cells from Oxidative DNA Damage Mol. Cell. Biol., December 1, 2005; 25(23): 10492 - 10506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Baird, T. Davis, J. Rowson, C. J. Jones, and D. Kipling Normal telomere erosion rates at the single cell level in Werner syndrome fibroblast cells Hum. Mol. Genet., July 15, 2004; 13(14): 1515 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Hunt, D. J. Dix, G. G. Sharma, R. K. Pandita, A. Gupta, M. Funk, and T. K. Pandita Genomic Instability and Enhanced Radiosensitivity in Hsp70.1- and Hsp70.3-Deficient Mice Mol. Cell. Biol., January 15, 2004; 24(2): 899 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Kyng, A. May, S. Kolvraa, and V. A. Bohr Gene expression profiling in Werner syndrome closely resembles that of normal aging PNAS, October 14, 2003; 100(21): 12259 - 12264. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Grandori, K.-J. Wu, P. Fernandez, C. Ngouenet, J. Grim, B. E. Clurman, M. J. Moser, J. Oshima, D. W. Russell, K. Swisshelm, et al. Werner syndrome protein limits MYC-induced cellular senescence Genes & Dev., July 1, 2003; 17(13): 1569 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L. Opresko, W.-H. Cheng, C. von Kobbe, J. A. Harrigan, and V. A. Bohr Werner syndrome and the function of the Werner protein; what they can teach us about the molecular aging process. Carcinogenesis, May 1, 2003; 24(5): 791 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Davis, S. K. Singhrao, F. S. Wyllie, M. F. Haughton, P. J. Smith, M. Wiltshire, D. Wynford-Thomas, C. J. Jones, R. G. A. Faragher, and D. Kipling Telomere-based proliferative lifespan barriers in Werner-syndrome fibroblasts involve both p53-dependent and p53-independent mechanisms J. Cell Sci., April 1, 2003; 116(7): 1349 - 1357. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fry The Werner Syndrome Helicase-Nuclease--One Protein, Many Mysteries Sci. Aging Knowl. Environ., April 3, 2002; 2002(13): re2 - 2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Droge Free Radicals in the Physiological Control of Cell Function Physiol Rev, January 1, 2002; 82(1): 47 - 95. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
